LDL-C Management Trends in ASCVD Patients
LDL-C Management Trends in ASCVD Patients
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
0.50 creditsSacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
Preventing Adverse Events in CAR T-Cell Therapy: The Evolution of Safety Protocols
Preventing Adverse Events in CAR T-Cell Therapy: The Evolution of Safety Protocols
Poster Pearl: Treating ER+/HER2- mBC with Elacestrant and Endocrine Therapy
Poster Pearl: Treating ER+/HER2- mBC with Elacestrant and Endocrine Therapy
The Switch-Ready Patient
The Switch-Ready Patient
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
0.50 creditsSacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
Mastering CAR-T Cell Therapy in R/R Large B-Cell Lymphoma: Adverse Event Management
Mastering CAR-T Cell Therapy in R/R Large B-Cell Lymphoma: Adverse Event Management
EMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i
EMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i
February 13, 2025
San Francisco, California
Personalizing Care Within the Advanced RCC Treatment Paradigm: A Fireside Chat and Roundtable Symposium
Clinical Insights into Higher-Risk MDS: Treatment Goals and Strategies
Clinical Insights into Higher-Risk MDS: Treatment Goals and Strategies
LDL-C Management Trends in ASCVD Patients
LDL-C Management Trends in ASCVD Patients
The Switch-Ready Patient
The Switch-Ready Patient
Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings
Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings
Treating Moderate-to-Severe Plaque Psoriasis in Patients 50+ Including the Medicare Population
Treating Moderate-to-Severe Plaque Psoriasis in Patients 50+ Including the Medicare Population
Tirzepatide reduces HF events in patients with HFpEF and obesity
Tirzepatide reduces HF events in patients with HFpEF and obesity
The AMA MAP™ Hypertension Program in Action: Insights from Grace Health
The AMA MAP™ Hypertension Program in Action: Insights from Grace Health
AI and EEG Detect Parkinson’s Diagnosis with Near-Perfect Accuracy
AI and EEG Detect Parkinson’s Diagnosis with Near-Perfect Accuracy
Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI
Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI
Holistic AI Models Revolutionizing Cancer Detection and Treatment
Holistic AI Models Revolutionizing Cancer Detection and Treatment
Investigating the Incidence of IgA Nephropathy Among Racial and Ethnic Groups
Investigating the Incidence of IgA Nephropathy Among Racial and Ethnic Groups
Can AI Help Streamline Emergency Medicine Handoffs?
Can AI Help Streamline Emergency Medicine Handoffs?
AI in Precision Medicine Market Poised to Reach Nearly $4 Billion by 2030
AI in Precision Medicine Market Poised to Reach Nearly $4 Billion by 2030
February 14, 2025
San Francisco, California
Think Tank Live: Collaborative Insights to Solve the Puzzle of Bladder Cancer
Think Tank Live: Collaborative Insights to Solve the Puzzle of Bladder Cancer
February 14, 2025
06:00 PM - 08:00 PM PST
Think Tank Live: Collaborative Insights to Solve the Puzzle of Bladder Cancer
New Hope Emerging in the Treatment of PTSD in Women: Overcoming Suboptimal Outcomes
New Hope Emerging in the Treatment of PTSD in Women: Overcoming Suboptimal Outcomes
0.75 creditsCardiorenal Collaboration: Escape the Treatment Trap
Cardiorenal Collaboration: Escape the Treatment Trap
1.00 creditsAdvancing ALK Inhibition Into Early-Stage NSCLC: Integrating Biomarker-Driven Therapies to Reduce Recurrence Risk Post Resection
Advancing ALK Inhibition Into Early-Stage NSCLC: Integrating Biomarker-Driven Therapies to Reduce Recurrence Risk Post Resection
0.25 creditsDecoding CIDP: Exploring Common and Atypical Variants
Decoding CIDP: Exploring Common and Atypical Variants
1.00 program creditsImproving Outcomes in hATTR-PN: The Role of Vigilant Symptom Assessment
Improving Outcomes in hATTR-PN: The Role of Vigilant Symptom Assessment
Advancements in Understanding ALS Treatment
Advancements in Understanding ALS Treatment
Objective Measures and Endoscopic Improvement
Objective Measures and Endoscopic Improvement
Best Practices for an Aesthetic Neurotoxin Approach
Best Practices for an Aesthetic Neurotoxin Approach
Expert Insights on Congenital Adrenal Hyperplasia Care From an Adult Endocrinologist
Expert Insights on Congenital Adrenal Hyperplasia Care From an Adult Endocrinologist
Digital Therapeutics Clinical Trials: From Design to Data Interpretation
Digital Therapeutics Clinical Trials: From Design to Data Interpretation